Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

992
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
992
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.6K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

371
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
371
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Expression of Nicotinic Receptors on iPSC-Derived Astrocytes and Signalling Disturbances by a Panel of Neonicotinoid Pesticides and Their Metabolites.

International journal of molecular sciences·2026
Same author

A Proteochemometric Model for Ligands of the SLC5 Transporter Family.

Archiv der Pharmazie·2026
Same author

What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate.

Frontiers in public health·2024
Same author

The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds.

Chemico-biological interactions·2021
Same author

Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.

Molecular medicine (Cambridge, Mass.)·2020
Same author

The RESOLUTE consortium: unlocking SLC transporters for drug discovery.

Nature reviews. Drug discovery·2020

Related Experiment Video

Updated: Apr 27, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K

'Big data' in pharmaceutical science: challenges and opportunities.

Al G Dossetter, Gerhard Ecker, Hugh Laverty

    Future Medicinal Chemistry
    |June 26, 2014
    PubMed
    Summary

    Big data is revolutionizing drug discovery and design. Experts discuss challenges and future adaptations for the pharmaceutical industry to leverage big data for scientific advancement.

    Area of Science:

    • Pharmaceutical Science
    • Computational Biology
    • Bioinformatics

    Background:

    • The integration of big data technologies is transforming the landscape of drug discovery and design.
    • Expert opinions are crucial for understanding the current impact and future trajectory of big data in this field.

    Purpose of the Study:

    • To capture expert perspectives on the role of big data in pharmaceutical science.
    • To identify challenges and opportunities associated with big data in drug discovery and design.
    • To speculate on the future evolution of big data applications in medicine.

    Main Methods:

    • Expert interviews and opinion collection.
    • Review of current big data implementation strategies.
    • Discussion of data quality, privacy, and industry adaptation.

    More Related Videos

    Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
    09:43

    Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

    Published on: November 22, 2019

    5.7K

    Related Experiment Videos

    Last Updated: Apr 27, 2026

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
    08:31

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

    Published on: December 1, 2020

    4.8K
    Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
    09:43

    Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

    Published on: November 22, 2019

    5.7K

    Main Results:

    • Big data offers significant contributions to advancing pharmaceutical science.
    • Key challenges include technology implementation, data quality, and privacy concerns.
    • The industry requires adaptation to fully embrace the big data era.

    Conclusions:

    • Big data is a pivotal force in modern drug discovery and design.
    • Addressing implementation challenges is essential for maximizing big data's potential.
    • Future pharmaceutical advancements will be significantly shaped by big data integration.